Selected research
Market Structure
Global Efavirenz Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Efavirenz Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Efavirenz Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Efavirenz Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Efavirenz Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Efavirenz Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Efavirenz Tablets include Aurobindo Pharma, Cipla, Hetero, Strides Pharma, Anhui Biochem Bio-Pharmaceutical, Huahai Pharmaceutical and DESANO, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Efavirenz Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Efavirenz Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Efavirenz Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Efavirenz Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.
Efavirenz Tablets Segment by Company
Aurobindo Pharma
Cipla
Hetero
Strides Pharma
Anhui Biochem Bio-Pharmaceutical
Huahai Pharmaceutical
DESANO
Efavirenz Tablets Segment by Type
200mg
50mg
600mg
Efavirenz Tablets Segment by Application
Adult
Child
Efavirenz Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Efavirenz Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Efavirenz Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Efavirenz Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Efavirenz Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Efavirenz Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Efavirenz Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Efavirenz Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 200mg
- 50mg
- 600mg
Applications
- Adult
- Child
Companies covered
- Aurobindo Pharma
- Cipla
- Hetero
- Strides Pharma
- Anhui Biochem Bio-Pharmaceutical
- Huahai Pharmaceutical
- DESANO
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Efavirenz Tablets Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Efavirenz Tablets Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Efavirenz Tablets Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Efavirenz Tablets Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Efavirenz Tablets Market Dynamics
- 2.1 Efavirenz Tablets Industry Trends
- 2.2 Efavirenz Tablets Industry Drivers
- 2.3 Efavirenz Tablets Industry Opportunities and Challenges
- 2.4 Efavirenz Tablets Industry Restraints
3 Efavirenz Tablets Market by Manufacturers
- 3.1 Global Efavirenz Tablets Revenue by Manufacturers (2021-2026)
- 3.2 Global Efavirenz Tablets Sales by Manufacturers (2021-2026)
- 3.3 Global Efavirenz Tablets Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Efavirenz Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Efavirenz Tablets Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Efavirenz Tablets Manufacturers, Product Type & Application
- 3.7 Global Efavirenz Tablets Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Efavirenz Tablets Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Efavirenz Tablets Players Market Share by Revenue in 2025
- 3.8.3 2025 Efavirenz Tablets Tier 1, Tier 2, and Tier 3
4 Efavirenz Tablets Market by Type
- 4.1 Efavirenz Tablets Type Introduction
- 4.1.1 200mg
- 4.1.2 50mg
- 4.1.3 600mg
- 4.2 Global Efavirenz Tablets Sales by Type
- 4.2.1 Global Efavirenz Tablets Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Efavirenz Tablets Sales by Type (2021-2032)
- 4.2.3 Global Efavirenz Tablets Sales Market Share by Type (2021-2032)
- 4.3 Global Efavirenz Tablets Revenue by Type
- 4.3.1 Global Efavirenz Tablets Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Efavirenz Tablets Revenue by Type (2021-2032)
- 4.3.3 Global Efavirenz Tablets Revenue Market Share by Type (2021-2032)
5 Efavirenz Tablets Market by Application
- 5.1 Efavirenz Tablets Application Introduction
- 5.1.1 Adult
- 5.1.2 Child
- 5.2 Global Efavirenz Tablets Sales by Application
- 5.2.1 Global Efavirenz Tablets Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Efavirenz Tablets Sales by Application (2021-2032)
- 5.2.3 Global Efavirenz Tablets Sales Market Share by Application (2021-2032)
- 5.3 Global Efavirenz Tablets Revenue by Application
- 5.3.1 Global Efavirenz Tablets Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Efavirenz Tablets Revenue by Application (2021-2032)
- 5.3.3 Global Efavirenz Tablets Revenue Market Share by Application (2021-2032)
6 Global Efavirenz Tablets Sales by Region
- 6.1 Global Efavirenz Tablets Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Efavirenz Tablets Sales by Region (2021-2032)
- 6.2.1 Global Efavirenz Tablets Sales by Region (2021-2026)
- 6.2.2 Global Efavirenz Tablets Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Efavirenz Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Efavirenz Tablets Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Efavirenz Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Efavirenz Tablets Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Efavirenz Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Efavirenz Tablets Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Efavirenz Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Efavirenz Tablets Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Efavirenz Tablets Revenue by Region
- 7.1 Global Efavirenz Tablets Revenue by Region
- 7.1.1 Global Efavirenz Tablets Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Efavirenz Tablets Revenue by Region (2021-2026)
- 7.1.3 Global Efavirenz Tablets Revenue by Region (2027-2032)
- 7.1.4 Global Efavirenz Tablets Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Efavirenz Tablets Revenue (2021-2032)
- 7.2.2 North America Efavirenz Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Efavirenz Tablets Revenue (2021-2032)
- 7.3.2 Europe Efavirenz Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Efavirenz Tablets Revenue (2021-2032)
- 7.4.2 Asia-Pacific Efavirenz Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Efavirenz Tablets Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Efavirenz Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Aurobindo Pharma
- 8.1.1 Aurobindo Pharma Company Information
- 8.1.2 Aurobindo Pharma Business Overview
- 8.1.3 Aurobindo Pharma Efavirenz Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Aurobindo Pharma Efavirenz Tablets Product Portfolio
- 8.1.5 Aurobindo Pharma Recent Developments
- 8.2 Cipla
- 8.2.1 Cipla Company Information
- 8.2.2 Cipla Business Overview
- 8.2.3 Cipla Efavirenz Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Cipla Efavirenz Tablets Product Portfolio
- 8.2.5 Cipla Recent Developments
- 8.3 Hetero
- 8.3.1 Hetero Company Information
- 8.3.2 Hetero Business Overview
- 8.3.3 Hetero Efavirenz Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Hetero Efavirenz Tablets Product Portfolio
- 8.3.5 Hetero Recent Developments
- 8.4 Strides Pharma
- 8.4.1 Strides Pharma Company Information
- 8.4.2 Strides Pharma Business Overview
- 8.4.3 Strides Pharma Efavirenz Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Strides Pharma Efavirenz Tablets Product Portfolio
- 8.4.5 Strides Pharma Recent Developments
- 8.5 Anhui Biochem Bio-Pharmaceutical
- 8.5.1 Anhui Biochem Bio-Pharmaceutical Company Information
- 8.5.2 Anhui Biochem Bio-Pharmaceutical Business Overview
- 8.5.3 Anhui Biochem Bio-Pharmaceutical Efavirenz Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Anhui Biochem Bio-Pharmaceutical Efavirenz Tablets Product Portfolio
- 8.5.5 Anhui Biochem Bio-Pharmaceutical Recent Developments
- 8.6 Huahai Pharmaceutical
- 8.6.1 Huahai Pharmaceutical Company Information
- 8.6.2 Huahai Pharmaceutical Business Overview
- 8.6.3 Huahai Pharmaceutical Efavirenz Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Huahai Pharmaceutical Efavirenz Tablets Product Portfolio
- 8.6.5 Huahai Pharmaceutical Recent Developments
- 8.7 DESANO
- 8.7.1 DESANO Company Information
- 8.7.2 DESANO Business Overview
- 8.7.3 DESANO Efavirenz Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 DESANO Efavirenz Tablets Product Portfolio
- 8.7.5 DESANO Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Efavirenz Tablets Value Chain Analysis
- 9.1.1 Efavirenz Tablets Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Efavirenz Tablets Production Mode & Process
- 9.2 Efavirenz Tablets Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Efavirenz Tablets Distributors
- 9.2.3 Efavirenz Tablets Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst